Atlas Trials

Bioequivalence Study of Sulfadoxine/ Pyrimethamine Tablets in Healthy Subjects Under Fasting Conditions

Clinical trial NCT04577469 · UNKNOWN

Trial details

NCT number
NCT04577469
Sponsor
Emzor Pharmaceutical Industries Limited
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence
Start date
2020-12-01
Primary completion
2020-12-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.